EU regulator backs revoking Amgen's right to sell rare-disease drug - Reuters
EU regulator backs revoking Amgen's right to sell rare-disease drug Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMi3AFBVV95cUxPQW1xek5kR0ljZzlCOUtEVnNfSWhSb2hVSVIxcTVGaWpoVllvaFF6VVhlNlRFNWtLWFFTc3lmcXpqZXZDOFk5UXFOZTdrTEdXS2diS0w0T21XWC1ZeVd1SUx2dXhTRU5HR1JGQUY3VTdKZlM5R2lzRFVDUl9KTVhmclRFSTV3aVU4MHBTd1BLZFRlM3NneUJkQTZXXzFmdm5rZFpfZmhUUkxpTWNiLVhOSVg5SkVqZ1RQSmNZSWY5YTI2TW5sX3NxOFk1bTU5TlpjZXhrUFI2TzRWZ2hE?oc=5" target="_blank">EU regulator backs revoking Amgen's right to sell rare-disease drug</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
US FDA approves Vera's kidney disease drug - Reuters
US FDA approves Vera's kidney disease drug Reuters
July 7, 2026 at 05:09 PMAstraZeneca, Daiichi near UK pricing deal for breast cancer drug, Bloomberg News reports - Reuters
AstraZeneca, Daiichi near UK pricing deal for breast cancer drug, Bloomberg News reports Reuters
July 8, 2026 at 06:34 PMSouth African regulators issue recall of Ozempic copies - Reuters
South African regulators issue recall of Ozempic copies Reuters
July 9, 2026 at 09:14 PMFDA approves at-home starter dose of Eisai-Biogen Alzheimer's drug - Reuters
FDA approves at-home starter dose of Eisai-Biogen Alzheimer's drug Reuters
July 13, 2026 at 08:59 PMUS FDA approves Celcuity's breast cancer drug - Reuters
US FDA approves Celcuity's breast cancer drug Reuters
July 14, 2026 at 10:36 PMUS FDA approves Sanofi's wearable injector form of blood cancer drug - Reuters
US FDA approves Sanofi's wearable injector form of blood cancer drug Reuters
July 10, 2026 at 05:49 PM